8-10 March 2010
Monaco

The Drug Information Association (DIA) invites you to join over 3,000 professionals from over 50 countries at the DIA’s 22nd Annual EuroMeeting. The meeting brings together professionals from the biopharmaceutical industry, contract service organisations, academic research centres, regulatory agencies, health ministries, patients’ organisations and trade associations. The 22nd Annual EuroMeeting provides an opportunity to:

• Attend presentations by more than 350 speakers
• Hear representatives from the EMEA, FDA and National Competent Authorities throughout Europe
• Attend pre-conference tutorials
• Network with professional colleagues from around the world
• Visit more than 250 exhibitors in Europe’s largest interactive exhibit hall
• Choose from over 110 sessions

Europe provides a contrasting perspective to the global drug market that is not fully understood by colleagues around the world. The EuroMeeting provides a once-a-year opportunity to explain it all.

Theme Highlights

Theme 1: Innovation

Is an Open Innovation Paradigm the Way Forward for Pharma?

Theme 2: Staying in Business: How to Make Sure you Comply With All Rules and Regulations

The Price of globalisation: Bringing Modern Therapies to Developing Countries or Only Including Patients in Trials? What should we all know about Indian Society, Medical Practice and Patients before Drawing Conclusions

Theme 3: Paediatric Medicines – Did the Regulation Deliver on its Promises?

Initial Impact of the Paediatric Regulation After 3 Years

Theme 4: Decision Making - The Key to Efficient and Effective Drug Development, Approval and Access

Influence of HTA on Regulatory Decision-Making: Reality? An Opportunity? A Threat?

Theme 5: Paving the Way for Advanced Therapies - Fostering New Generations of Biotechnology-Derived Medicines

CAT Experience in the First Year

Theme 6: Challenges for Switching Centrally Authorised Products from Prescription to Non-Prescription Status

Could the UK Model Be Reproduced at EU Level?

Theme 7: Personalised Medicine

The EMEA’s New Biomarker Qualification Process: How Does it Work and Where Does it Fit?

Theme 8: Taking the European Regulatory Infrastructure Forward

Pharmaceutical Package - The Latest Information

Theme 9: Risk Management

Research Initiatives in Risk Management

Theme 10: The Informed Patient

Pharmaceutical Package: Information to Patient Proposals - What Difference will They Make?

Theme 11: eHealth

Connecting Healthcare and Clinical Research

Theme 12: Pharmaceutical Sciences in 2020

What Major Research Activities Will Drive Drug Discovery and Development?

Theme 13: Handling Clinical Trials, eSubmissions and Quality Requests

Emerging Standards from ICH

Hot Topic:

Exploratory Clinical Trials in the EU

Exhibit at the EuroMeeting 2010

Please call Natacha Scholl at the DIA in Europe, on +41 61 225 51 59, or email: exhibition@diaeurope.org

For more information on the EuroMeeting, please contact the Customer Services Team on +41 61 225 51 51, or email: diaeurope@diaeurope.org

We look forward to welcoming you to Monaco in March 2010.